| Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures Y Şenbabaoğlu, RS Gejman, AG Winer, M Liu, EM Van Allen, ... Genome biology 17, 1-25, 2016 | 790 | 2016 |
| Kinase regulation of human MHC class I molecule expression on cancer cells EJ Brea, CY Oh, E Manchado, S Budhu, RS Gejman, G Mo, P Mondello, ... Cancer immunology research 4 (11), 936-947, 2016 | 158 | 2016 |
| Rejection of immunogenic tumor clones is limited by clonal fraction RS Gejman, AY Chang, HF Jones, K DiKun, AA Hakimi, A Schietinger, ... Elife 7, e41090, 2018 | 111 | 2018 |
| A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens AY Chang, T Dao, RS Gejman, CA Jarvis, A Scott, L Dubrovsky, ... The Journal of clinical investigation 127 (7), 2705-2718, 2017 | 103 | 2017 |
| Opportunities and challenges for TCR mimic antibodies in cancer therapy AY Chang, RS Gejman, EJ Brea, CY Oh, MD Mathias, D Pankov, E Casey, ... Expert opinion on biological therapy 16 (8), 979-987, 2016 | 57 | 2016 |
| T cell receptor mimic antibodies for cancer therapy L Dubrovsky, T Dao, RS Gejman, EJ Brea, AY Chang, CY Oh, E Casey, ... Oncoimmunology 5 (1), e1049803, 2016 | 43 | 2016 |
| Identification of the targets of T cell receptor therapeutic agents and cells by use of a high throughput genetic platform RS Gejman, HF Jones, MG Klatt, AY Chang, CY Oh, SS Chandran, ... Cancer Immunology Research, 267047, 2020 | 32 | 2020 |
| Kinase regulation of human MHC class I molecule expression on cancer cells. Cancer Immunol Res. 2016; 4 (11): 936–947. doi: 10.1158/2326-6066 EJ Brea, CY Oh, E Manchado, S Budhu, RS Gejman, G Mo, P Mondello, ... CIR-16-0177, 0 | 14 | |
| Cytokine response over the course of COVID-19 infection in pregnant women DB Rosen, EA Murphy, RS Gejman, A Capili, RL Friedlander, S Rand, ... Cytokine 154, 155894, 2022 | 11 | 2022 |
| Unmasking the suppressed immunopeptidome of EZH2-mutated diffuse large B-cell lymphomas through combination drug treatment CM Bourne, SS Mun, T Dao, ZEH Aretz, Z Molvi, RS Gejman, A Daman, ... Blood Advances 6 (14), 4107-4121, 2022 | 7 | 2022 |
| An input-controlled model system for identification of MHC bound peptides enabling laboratory comparisons of immunopeptidome experiments MG Klatt, ZEH Aretz, M Curcio, RS Gejman, HF Jones, DA Scheinberg Journal of proteomics 228, 103921, 2020 | 3 | 2020 |
| Erratum to: Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures. Y ÅenbabaoÄlu, RS Gejman, AG Winer, M Liu, EM Van Allen, ... Genome Biology 18 (1), NA-NA, 2017 | 2 | 2017 |
| Methods and compositions for t-cell epitope screening DA Scheinberg, R Gejman US Patent App. 16/333,109, 2019 | | 2019 |
Casey A. JarvisVerified email at usc.edu
